Mon, October 3, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Patrick Hummel Maintained (TSLA) at Strong Buy and Held Target at $367 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
William Stein Maintained (TSLA) at Strong Buy with Increased Target to $348 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
David Begleiter Maintained (TROX) at Strong Buy with Decreased Target to $18 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $114 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
David Coleman Downgraded (THO) to Hold on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Crispin Love Maintained (TPVG) at Buy with Decreased Target to $15 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Ravi Shanker Maintained (UNP) at Hold with Decreased Target to $187 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Ravi Shanker Maintained (UPS) at Sell with Decreased Target to $100 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Brian Nowak Maintained (UBER) at Buy with Decreased Target to $54 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
James Faucette Maintained (V) at Buy with Decreased Target to $282 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (VCTR) at Sell with Decreased Target to $20 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Alexander Blostein Maintained (VCTR) at Strong Buy with Decreased Target to $27 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Lee Horowitz Initiated (VCSA) at Hold and Held Target at $60 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Ravi Shanker Maintained (ALGT) at Buy with Decreased Target to $190 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Paul Fremont Maintained (ALE) at Hold with Decreased Target to $50 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Matthew DeYoe Maintained (ALB) at Hold with Increased Target to $332 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (BEN) at Sell with Decreased Target to $20 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Alexander Blostein Maintained (BEN) at Strong Sell with Decreased Target to $21 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Leithead Maintained (BERY) at Hold with Decreased Target to $55 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Nicholas Campanella Initiated (CEG) at Buy and Held Target at $98 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Ravi Shanker Maintained (CSX) at Sell with Decreased Target to $23 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
David Begleiter Maintained (CE) at Strong Buy with Decreased Target to $110 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Christopher Stathoulopoulos Maintained (CCL) at Hold with Decreased Target to $8 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Benjamin Chaiken Maintained (CCL) at Buy with Decreased Target to $22 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Brandt Montour Maintained (CCL) at Buy with Decreased Target to $10 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Leithead Maintained (CCK) at Buy with Decreased Target to $115 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Brandon Nispel Maintained (CCI) at Buy with Decreased Target to $177 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Josh Baer Maintained (SMAR) at Buy with Decreased Target to $54 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Chris Carey Maintained (SMG) at Hold with Decreased Target to $50 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Francois Brisebois Upgraded (SNSE) to Buy and Held Target at $5 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Toni Kaplan Maintained (SPGI) at Buy with Decreased Target to $380 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
George Tong Maintained (SPGI) at Strong Buy with Decreased Target to $364 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Chris Carey Maintained (SPB) at Buy with Decreased Target to $70 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Anthony Crowdell Maintained (SRE) at Strong Buy with Decreased Target to $81 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Julian Mitchell Maintained (VNT) at Buy with Decreased Target to $30 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (VRTS) at Sell with Decreased Target to $156 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Philip Ng Maintained (SUM) at Strong Buy with Decreased Target to $35 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Julian Mitchell Maintained (SWK) at Buy with Decreased Target to $118 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Chris Carey Maintained (TAP) at Hold with Decreased Target to $52 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Richard Ramsden Downgraded (C) to Hold and Decreased Target to $47 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Josh Baer Upgraded (BOX) to Buy and Increased Target to $34 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Alexander Blostein Maintained (BX) at Strong Buy with Decreased Target to $101 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (BSIG) at Hold with Decreased Target to $17 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Jiong Shao Maintained (BABA) at Buy with Decreased Target to $135 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Michael Cyprys Maintained (BLK) at Buy with Decreased Target to $754 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Maury Raycroft Maintained (ALNY) at Strong Buy with Increased Target to $232 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Julian Mitchell Maintained (ALLE) at Buy with Decreased Target to $115 on, Oct 3rd, 2022
[ Mon, Oct 03rd 2022 ]: WOPRAI
Jimmy Bhullar Maintained (ALL) at Buy with Increased Target to $152 on, Oct 3rd, 2022

Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Increased Target to $50 on, Oct 3rd, 2022

Neena Bitritto-Garg of Citigroup, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $48 to $50 on, Oct 3rd, 2022.

Neena has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $40 on, Friday, September 9th, 2022


This is the rating of the analyst that currently disagrees with Neena

  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $50 on, Thursday, September 8th, 2022